Fibromyalgia is a chronic condition affecting between 2% and 6% of the global population, characterized by widespread, persistent pain often associated with fatigue, sleep disturbances, cognitive difficulties and affective symptoms. Despite its high prevalence—particularly among women—the mechanisms contributing to the development and persistence of the disease are not yet fully understood.
New pathways identified to alleviate fibromyalgia pain and depressive symptoms
A study has identified new pathways to reduce pain and depressive symptoms associated with fibromyalgia, a chronic condition affecting 2% to 6% of the global population, particularly women. This research is significant as it addresses a prevalent health issue that may impact the Iranian population. Understanding and treating fibromyalgia could improve the quality of life for many in Iran.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%